TIMD4 and ovarian cancer: In a mouse model of ovarian cancer with peritoneal metastasis, TIM4+ TAMs reduce mTORC1 activity through arginase-1-mediated arginine depletion, exhibiting higher mitochondrial OXPHOS and mitophagy activity, thus promoting ovarian cancer growth and peritoneal metastasis 33.